Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1997 Jun;87(6):922–925. doi: 10.2105/ajph.87.6.922

Ethical dilemmas in current planning for polio eradication.

C E Taylor 1, F Cutts 1, M E Taylor 1
PMCID: PMC1380923  PMID: 9224170

Abstract

Intensification of polio eradication efforts worldwide raises concerns about costs and benefits for poor countries. A major argument for global funding is the high benefit-cost ratio of eradication; however, financial benefits are greatest for rich countries. By contrast, the greatest costs are borne by poor countries; the Pan American Health Organization has estimated that host countries bore 80% of costs for polio eradication in the Americas. The 1988 World Health Assembly resolution setting up the Polio Eradication Initiative carried the proviso that programs should strengthen health infrastructures. Drastic cuts in donor funding for health make this commitment even more important. Two international evaluations have reported both positive and negative effects of polio and Expanded Programme on Immunization programs on the functioning and sustainability of primary health care. Negative effects were greatest in poor countries with many other diseases of public health importance. If poor countries are expected to divert funds from their own urgent priorities, donors should make solid commitments to long-term support for sustainable health development.

Full text

PDF
922

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel-Smith B. The world economic crisis. Part 1: Repercussions on health. Health Policy Plan. 1986 Sep;1(3):202–213. doi: 10.1093/heapol/1.3.202. [DOI] [PubMed] [Google Scholar]
  2. Bart K. J., Foulds J., Patriarca P. Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ. 1996;74(1):35–45. [PMC free article] [PubMed] [Google Scholar]
  3. Evans I. SAPping maternal health. Lancet. 1995 Oct 21;346(8982):1046–1046. doi: 10.1016/s0140-6736(95)91733-0. [DOI] [PubMed] [Google Scholar]
  4. Hull H. F., Ward N. A., Hull B. P., Milstien J. B., de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet. 1994 May 28;343(8909):1331–1337. doi: 10.1016/s0140-6736(94)92472-4. [DOI] [PubMed] [Google Scholar]
  5. Rodríguez Cruz R. Cuba: mass polio vaccination program, 1962-1982. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S408–S412. [PubMed] [Google Scholar]
  6. Sutter R. W., Onorato I. M., Patriarca P. A. Current poliomyelitis immunization policy in the United States. Pediatr Ann. 1990 Dec;19(12):702–706. doi: 10.3928/0090-4481-19901201-08. [DOI] [PubMed] [Google Scholar]
  7. de Quadros C. A., Olivé J. M., Hersh B. S., Strassburg M. A., Henderson D. A., Brandling-Bennett D., Alleyne G. A. Measles elimination in the Americas. Evolving strategies. JAMA. 1996 Jan 17;275(3):224–229. doi: 10.1001/jama.275.3.224. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES